NeoGenomics, Inc. Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, Year One
NeoGenomics, Inc. (NEO) had Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, Year One of $8.96 million as of 2025-06-30, per its 10-Q filed 2025-07-29.
Financial Statements › Notes › Debt and Equity Securities › Debt Securities, Available-for-Sale, Maturity, Allocated and Single Maturity Date, Fair Value
us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue · last filed 2026-02-17
- 2025-06-30: Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, Year One $8.96M.
- 2025-03-31: Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, Year One $11.89M.
- 2024-12-31: Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, Year One $19.83M.
- 2024-09-30: Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, Year One $25.82M.
| Period end | Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, Year One |
|---|---|
| 2025-06-30 | $8.96M 10-Q · filed 2025-07-29 |
| 2025-03-31 | $11.89M 10-Q · filed 2025-04-29 |
| 2024-12-31 | $19.83M 10-K · filed 2026-02-17 |
| 2024-09-30 | $25.82M 10-Q · filed 2024-11-05 |
| 2024-06-30 | $24.16M 10-Q · filed 2024-07-30 |
| 2024-03-31 | $41.46M 10-Q · filed 2024-04-30 |
| 2023-12-31 | $55.48M 10-K · filed 2025-02-18 |
| 2023-09-30 | $72.11M 10-Q · filed 2023-11-06 |
| 2023-06-30 | $88.70M 10-Q · filed 2023-08-08 |
| 2023-03-31 | $93.39M 10-Q · filed 2023-05-09 |
| 2022-12-31 | $111.41M 10-K · filed 2024-02-20 |
| 2022-09-30 | $112.17M 10-Q · filed 2022-11-08 |
| 2022-06-30 | $104.60M 10-Q · filed 2022-08-09 |
| 2022-03-31 | $108.39M 10-Q · filed 2022-05-09 |
| 2021-12-31 | $104.71M 10-K · filed 2023-02-24 |
| 2021-09-30 | $75.69M 10-Q · filed 2021-11-04 |
| 2021-06-30 | $70.90M 10-Q · filed 2021-08-09 |
| 2021-03-31 | $55.03M 10-Q · filed 2021-05-06 |
| 2020-12-31 | $27.04M 10-K · filed 2022-02-25 |
| 2020-09-30 | $19.42M 10-Q · filed 2020-10-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| 20/20 Biolabs, Inc. (AIDX) | United States | $0.005B |